Sometime in the future, doctors treating a patient infected with COVID-19 or lung cancer could administer a revolutionary new pharmaceutical therapy created by Madison-based biotech Nano RED. Carried by the bloodstream to the lungs, Nano RED’s therapy binds to the surface proteins on lung cells that the virus typically latches onto. When a viral particle … Continue reading Madison’s Nano RED biotech develops viral therapy platform for COVID-19, lung cancer